Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > IF Successful for NMIBC

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Mar 04, 2021 12:58pm

173 Views

Post# 32716151

RE:RE:RE:IF Successful for NMIBC

Amgen just bought out a P3 ready drug not yet approved for $2 Billion. After approval we may see much more than that. Imo. Time will tell. https://endpts.com/amgen-snaps-up-cancer-drug-player-five-prime-adding-phiii-ready-fgfr2b-drug-in-2b-ma-play/

enriquesuave wrote:
2 Billion BO if successful is very reasonable my estimate is $2 Billion on the low end and up to 12$ Billion, could be more? US dollars of course. Realistic expectations on successful trials. IMO

Rumpl3StiltSkin wrote:

enriquesuave wrote: and I sure believe so, then Theralase should do a PH2/3 trial for muscle-invasive non-metastatic bladder cancer. Should be very similar in procedure as for NMIBC. All IMo

Yes and hopefully this MIBC study will start out as a BTD. Asfar as Where SP is headed, there is too much IP here if proven for NMIBC or Covid 19. I expect a minimum $2B US buyout in at least a small bidding skirmish.